Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
NCT00174967
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
Placebo
DRUG:
Febuxostat
DRUG:
Febuxostat
DRUG:
Febuxostat
Sponsor
Takeda